Zevra Therapeutics, Inc. (ZVRA) Operating cash flow 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.6MFY2025 · since FY2016: -$29.8M → -$1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.6M | +97.7% |
| FY2024 | -$69.7M | -107.7% |
| FY2023 | -$33.5M | -79.2% |
| FY2022 | -$18.7M | -279.3% |
| FY2021 | $10.4M | +638.4% |
| FY2020 | -$1.9M | +91.8% |
| FY2019 | -$23.7M | +56.2% |
| FY2018 | -$54.2M | -63.8% |
| FY2017 | -$33.1M | -11.2% |
| FY2016 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA RevenueZVRA Net incomeZVRA Net marginZVRA Gross profitZVRA Gross marginZVRA Operating incomeZVRA Operating marginZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Stock buybacksZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →